Skip to content

Organon OGN Total debt

Total debt at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.06B+15.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.57B+17.7%
Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
Biogen logo
BiogenBIIB
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's total debt?
Organon (OGN) reported total debt of $8.57B in Q1 2026.
How has Organon's total debt changed year-over-year?
Organon's total debt decreased by 4.3% year-over-year, from $8.96B to $8.57B.
What is the long-term trend for Organon's total debt?
Over 5 years (2020 to 2025), Organon's total debt has grown at a 209.5% compound annual growth rate (CAGR), from $31M to $8.8B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.